| Cinnamon potential in alleviating early postmenopause symptoms: a randomized clinical trial 2024 · intervention group · Postmenopausal women aged 45–60 years, 1–3 years after their last menstrual period | 1 g | 60 days | 30 |
| Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects 2009 · 1 g cinnamon · Healthy subjects; age and sex not specified. | 1 g | 1 day | 15 |
| Cinnamon (Cinnamomum cassia) water extract improves diarrhea symptoms by changing the gut environment: a randomized controlled trial 2023 · CWE group · Subjects with diarrhea symptoms; age and sex not specified | 800 mg | 8 weeks | — |
| Cinnamon Infusion Reduces Satiety and Increases Energy Intake: A Randomized Crossover Trial 2022 · cinnamon infusion · 21 healthy volunteers; age and sex not specified | 2 g | 1 day | 21 |
| Turmeric improves post-prandial working memory in pre-diabetes independent of insulin 2014 · cinnamon · Adults aged 60 years or older with newly recognised, untreated pre-diabetes | 2 g | 1 day | 12 |
| Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial 2014 · cinnamon supplements · Women with polycystic ovary syndrome (PCOS); age and sex details beyond women are not reported | 1.5 g | 26 weeks | — |
| Effect of cinnamon on migraine attacks and inflammatory markers: A randomized double-blind placebo-controlled trial 2020 · cinnamon powder · patients with migraine | 1.8 g | 60 days | — |
| Effects of Cinnamomum zeylanicum (Ceylon cinnamon) extract on lipid profile, glucose levels and its safety in adults: A randomized, double-blind, controlled trial 2025 · C. zeylanicum extract group · Adults aged 18–70 with LDL-C between 100 and 190 mg/dL; mixed sex, with varying glycemic status including normoglycemia, prediabetes, and type 2 diabetes | 1 g | 12 weeks | 75 |
| Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial 2009 · usual care plus cinnamon capsules · Pediatric, adult, and geriatric patients with type 2 diabetes and HbA1c >7.0 | 1 g | 90 days | — |
| Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects 2009 · 3 g cinnamon · Healthy subjects; age and sex not specified. | 3 g | 1 day | 15 |
| Turmeric improves post-prandial working memory in pre-diabetes independent of insulin 2014 · turmeric and cinnamon · Adults aged 60 years or older with newly recognised, untreated pre-diabetes | 2 g | 1 day | 12 |
| Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial 2010 · cinnamon group · Adults with type 2 diabetes, aged 54.9 ± 9.8 years, treated with hypoglycemic agents and with HbA1c >7% | 2 g | 12 weeks | — |
| Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome 2024 · oral supplement group · Adults over 18 with overweight and metabolic syndrome, including people with type 2 diabetes or impaired glucose tolerance; men and women | 250 mg | 16 weeks | 29 |
| Effects of Aphrodite (an Herbal Compound) on SSRI-Induced Sexual Dysfunctions and Depression in Females with Major Depressive Disorder: Findings from a Randomized Clinical Trial 2023 · Aphrodite · Females aged 18–50 with major depressive disorder and SSRI-induced sexual dysfunction, taking sertraline | 11 mg | 8 weeks | 22 |
| Cinnamon improves glucose and lipids of people with type 2 diabetes 2003 · Group 1 · Adults aged 52.2 ± 6.32 years with type 2 diabetes; men and women | 1 g | 40 days | — |
| Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial 2019 · Cinnamon, BMI ≥ 27 · Patients with type II diabetes mellitus and BMI ≥ 27 | 1 g | 90 days | — |
| Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial 2019 · Cinnamon, BMI < 27 · Patients with type II diabetes mellitus and BMI < 27 | 1 g | 90 days | — |
| Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome 2018 · cinnamon group · Overweight or obese women with polycystic ovary syndrome | 1.5 g | 8 weeks | 42 |
| Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese 2009 · Cinnamon extract group · Overweight or obese people with impaired fasting glucose, BMI 25–45; age and sex not specified | 500 mg | 12 weeks | — |
| Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes 2012 · high-dose supplementation with cinnamon extract · Chinese patients with type 2 diabetes | 360 mg | 90 days | — |
| Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients 2014 · cinnamon group · Adults with nonalcoholic fatty liver disease; age and sex not reported | 1.5 g | 12 weeks | — |
| Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial 2018 · cinnamon group · Women with polycystic ovary syndrome (PCOS); age not reported | 1.5 g | 12 weeks | — |
| Effectiveness of cinnamon in the reduction of lipid levels in people with diabetes: a randomized clinical trial 2023 · experimental group · People aged 18–80 with type 2 diabetes using oral antidiabetics | 3 g | 90 days | 71 |
| Effect of oral cinnamon intervention on metabolic profile and body composition of Asian Indians with metabolic syndrome: a randomized double -blind control trial 2017 · Cinnamon group · Asian Indian men and women, mean age 44.8 years, with metabolic syndrome; all were treatment-naïve for the syndrome | 3 g | 16 weeks | 58 |
| Effect of oral cinnamon intervention on metabolic profile and body composition of Asian Indians with metabolic syndrome: a randomized double -blind control trial 2017 · Cinnamon group · Asian Indian men and women, mean age 44.8 years, with metabolic syndrome; all were treatment-naïve for the syndrome | 3 g | 16 weeks | 58 |
| Effect of ground cinnamon on postprandial blood glucose concentration in normal-weight and obese adults 2012 · cinnamon with cereal · Healthy adults aged 18–30 years, including normal-weight adults and adults with obesity | 6 g | 1 day | 30 |
| The Effect of Therapeutic Doses of Culinary Spices in Metabolic Syndrome: A Randomized Controlled Trial 2024 · cinnamon group · Adults aged 18–50 at risk of metabolic syndrome or with metabolic syndrome; men and women | 3 g | 12 weeks | 30 |
| Characterization and Pharmacokinetic Profile of Herbs and Spices' Phytochemicals over 24 h after Consumption in Overweight/Obese Adults 2023 · Cinnamon · Overweight/obese adults; mean age 37 ± 3 years; sex not stated | 6 g | 1 day | 24 |
| Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial 2024 · 3gPowder · Men aged 30–60 with type 2 diabetes mellitus | 3 g | 1 day | 19 |
| Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial 2024 · 6gPowder · Men aged 30–60 with type 2 diabetes mellitus | 6 g | 1 day | 19 |
| Effect of cinnamon spice on continuously monitored glycemic response in adults with prediabetes: a 4-week randomized controlled crossover trial 2024 · cinnamon · Adults with obesity and prediabetes; mean age 51.1 years | 4 g | 4 weeks | 18 |
| Effect of Cinnamon Tea on Postprandial Glucose Concentration 2015 · OGTT cinnamon group · Nondiabetic adults aged 20–53 years, both genders | 6 g | 1 day | 15 |
| Cassia Cinnamon Supplementation Reduces Peak Blood Glucose Responses but Does Not Improve Insulin Resistance and Sensitivity in Young, Sedentary, Obese Women 2016 · Cassia cinnamon (CASS) · Young, sedentary, obese women | 5 g | 1 day | 10 |
| Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans 2009 · cinnamon supplementation · Eight healthy men, aged 25 ± 1 years | 3 g | 2 weeks | 8 |
| Effects of short-term cinnamon ingestion on in vivo glucose tolerance 2007 · OGTT(cin) · Lean healthy men, aged 26 ± 1 years | 5 g | 1 day | 7 |
| Effects of short-term cinnamon ingestion on in vivo glucose tolerance 2007 · OGTT(cin12hpre) · Lean healthy men, aged 26 ± 1 years | 5 g | 1 day | 7 |
| Cinnamon improves glucose and lipids of people with type 2 diabetes 2003 · Group 2 · Adults aged 52.2 ± 6.32 years with type 2 diabetes; men and women | 3 g | 40 days | — |
| Cinnamon improves glucose and lipids of people with type 2 diabetes 2003 · Group 3 · Adults aged 52.2 ± 6.32 years with type 2 diabetes; men and women | 6 g | 40 days | — |
| Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2 2006 · cinnamon extract · Patients with type 2 diabetes not on insulin therapy, treated with oral antidiabetics or diet; age and sex not specified | 3 g | 120 days | — |
| Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes 2012 · low-dose supplementation with cinnamon extract · Chinese patients with type 2 diabetes | 120 mg | 90 days | — |
| A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial 2015 · Dietary supplement (Glycabiane) · Adults aged 25–65 years, overweight or obese, with pre-diabetes/impaired fasting glucose | 456 mg | 120 days | 26 |